Filter
299
Text search:
Tablet
Featured
Recommendations
48
New Publications
92
Language
Document type
No document type
181
Guidelines
44
Studies & Reports
29
Manuals
21
Training Material
10
Strategic & Response Plan
6
Brochures
2
Resource Platforms
2
Fact sheets
2
Infographics
1
Online Courses
1
Countries / Regions
India
19
Ethiopia
14
Indonesia
12
Nigeria
11
Nepal
11
Rwanda
8
Uganda
7
Kenya
7
South Africa
7
Tanzania
6
Sierra Leone
5
Philippines
5
Bangladesh
5
Malawi
5
Liberia
4
Senegal
3
Ghana
3
Zambia
3
Cambodia
3
Western and Central Europe
3
Africa
3
Global
3
Guinea
2
Burkina Faso
2
Mali
2
Cameroon
2
Haiti
2
Syria
2
Brazil
2
Lesotho
2
South–East Asia Region
2
Latin America and the Carribbean
2
Russia
2
Congo, Democratic Republic of
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Niger
1
Zimbabwe
1
Somalia
1
South Sudan
1
Afghanistan
1
Germany
1
Chad
1
Gambia
1
Mauritania
1
Papua New Guinea
1
Sudan
1
Namibia
1
Eswatini/ Swaziland
1
Ukraine
1
Botswana
1
Myanmar / Burma
1
West and Central Africa
1
Western Pacific Region
1
Paraguay
1
Asia
1
Eastern Europe
1
Tajikistan
1
Moldova
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
133
Clinical Guidelines
46
Women & Child Health
23
Key Resources
9
Public Health
8
Capacity Building
5
Pharmacy & Technologies
2
Toolboxes
HIV
29
Pharmacy
21
TB
14
NTDs
14
Mental Health
13
COVID-19
11
Conflict
7
Ebola & Marburg
6
Refugee
6
Disability
5
Natural Hazards
5
Caregiver
5
Cholera
4
NCDs
4
Specific Hazards
3
AMR
3
Polio
2
Rapid Response
2
Malaria
2
Social Ethics
1
Lateral-flow rapid diagnostic tests (RDTs) continue to play a vital role in global health in the management and diagnosis of infectious diseases, including malaria, HIV and COVID-19. Visually interpreted RDTs, more than any other class of diagnostics, fulfil WHO’s ASSURED criteria,1 enabling their
...
PLOS Glob Public Health 4(12): e0004035. https://doi. org/10.1371/journal.pgph.0004035.
A new formulation of praziquantel, arpraziquantel (arPZQ), has been developed for preschool-
aged children (PSAC) to fill the treatment gap for this age group in schistosomiasis control and
elimination program
...
This diagnostic and treatment manual is designed for use by medical professionals involved in curative care at the dispensary and hospital levels. We have tried to respond in the simplest and most practical way possible to the questions and problems faced by field medical staff, using the accumulate
...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals.
Pharmaceutical and Therapeutics Committees (PTCs) are responsible for ensuring the availability of medicines listed in the PHC EML at those facilities, as
...
Birth defect has been an emerging major cause of child mortality in the region. Scarcity of the birth defects information hampers policy decisions and control measures at national level. In order to create evidence for action for birth defects prevention in the region, WHO-SEARO in collaboration wit
...
Special Issue: Special Education in Sub-Saharan Africa | This special issue of our Communication*Support*World*Network*Newsletter attempts to share practical ideas and information about special education for children with disabilities in sub-Saharan Africa. Our intent is to begin a dialogue among th
...
This document provides guidance for countries on how to implement activities to achieve the interruption of yaws transmission. It is intended for use by national yaws eradication programmes, partners involved in the implementation of yaws eradication activities and WHO technical staff who provide te
...
3rd edition!
Indonesia Health Profile 2015
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults,
...
